PedAM
Pediatric Disease Annotations & Medicines
| Disease | polycystic ovary syndrome |
| Phenotype | C0948265|metabolic syndrome |
| Sentences | 24 |
| PubMedID- 24592034 | Objective: to identify biochemical factors that serve as predictors for the metabolic syndrome (mets) in patients with polycystic ovary syndrome (pcos) and to investigate the value of adipocytokines in the prediction of metabolic syndrome. |
| PubMedID- 23656383 | Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 20396356 | [clinical features of the metabolic syndrome in patients with polycystic ovary syndrome]. |
| PubMedID- 22985575 | Objective: to study the characteristics of the metabolic syndrome (ms) in patients with polycystic ovary syndrome (pcos). |
| PubMedID- 20540665 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. |
| PubMedID- 20199774 | Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 23885694 | Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 21962027 | polycystic ovary syndrome (pcos) is associated with the metabolic syndrome (mets). |
| PubMedID- 21251033 | Articles were summarised and grouped according to different sections defining interactions of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease as well as risk factors, pathogenic pathways and treatment options. |
| PubMedID- 21956415 | Context: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (cvd) and related mortality later in life. |
| PubMedID- 21550088 | Both vitamin d deficiency and polycystic ovary syndrome (pcos) are associated with aspects of metabolic syndrome, but it is unclear whether vitamin d deficiency contributes to the metabolic disturbances commonly found in women with pcos. |
| PubMedID- 22888988 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 20807165 | metabolic syndrome in adolescents with polycystic ovary syndrome. |
| PubMedID- 22870011 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south india. |
| PubMedID- 23426706 | Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 20852028 | Objective: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome. |
| PubMedID- 21450287 | Objective: to determine prevalence of metabolic syndrome in adolescents with polycystic ovary syndrome (pcos) and derive features suggestive of propensity for development of metabolic syndrome. |
| PubMedID- 23028012 | In this context, polycystic ovary syndrome, associated with the metabolic syndrome and high testosterone levels, is the most common cause of irregular periods in young women and could underlie an association between asthma and sex-hormone levels (3). |
| PubMedID- 21277789 | Women of reproductive age are not spared from the complications of metabolic syndrome, which overlaps with obesity and polycystic ovary syndrome (pcos), both of which are linked to infertility and poor reproductive outcome. |
| PubMedID- 23283052 | Objective: the aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with polycystic ovary syndrome (pcos). |
| PubMedID- 26488852 | Targets to treat metabolic syndrome in polycystic ovary syndrome. |
| PubMedID- 21756079 | Objective: based on the role of polycystic ovary syndrome as a cause of metabolic syndrome with chronic anovulation, obesity, hyperinsulinemia and hyperandrogenism, development of effective treatment for its obesity is a priority. |
| PubMedID- 20925278 | [the prevalence of metabolic syndrome in women with polycystic ovary syndrome]. |
| PubMedID- 21114431 | Background: both non-alcoholic steatohepatitis (nash) and polycystic ovary syndrome (pcos) are associated with metabolic syndrome (ms) and insulin resistance (ir). |
Page: 1